BIOGEN INC. (BIIB) Debt Components
- 2026-03-31: Notes Payable, CurrentUSD (m); Debt, CurrentUSD (m); Notes PayableUSD $6.29B; Long-term DebtUSD $6.29B.
- 2025-12-31: Notes Payable, CurrentUSD (m); Debt, CurrentUSD (m); Notes PayableUSD $6.29B; Long-term DebtUSD $6.29B.
- 2025-12-31: Notes Payable, CurrentUSD (m); Debt, CurrentUSD $0.00; Notes PayableUSD (m); Long-term DebtUSD (m).
- 2025-09-30: Notes Payable, CurrentUSD $0.00; Debt, CurrentUSD (m); Notes PayableUSD $6.29B; Long-term DebtUSD $6.29B.
BIOGEN INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |